Health Condition 1: L905- Scar conditions and fibrosis of skin
Conditions
Interventions
Intervention1: Radiofrequency-assisted subcision: radiofrequency-assisted subcision performed using an insulated RF cannula/microelectrode at the deep dermis superficial subcutaneous plane. RF paramet
Sponsors
CUTIS Academy of Cutaneous Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female patients aged 18 45 years. 2. Presence of clinically diagnosed atrophic acne scars (rolling, boxcar, icepick) graded by Goodman & Baron system.(I to IV) 3. Patients willing to undergo a single session of RF-assisted subcision. 4. Patients able and willing to provide written informed consent. 5. Patients willing to comply with follow-up visits at 3 and 6 months.
Exclusion criteria
Exclusion criteria: 1. Active acne, infections, or inflammatory dermatoses on the treatment area. 2. Hypertrophic or keloidal scars as the primary scar type. 3. History of keloidal tendancy 4. History of anticoagulant therapy 5. History of known hypersensitivity to lignocaine and prilocaine 6. Use of oral isotretinoin within the last 3 months. 7. Pregnant or lactating women. 8. Patients with significant systemic illnesses (uncontrolled diabetes, bleeding disorders, immunosuppression). 9.Patients with implanted electronic devices (pacemakers, defibrillators) contraindicated for RF procedures. 10. History of cosmetic procedures for acne scars (laser, peels, microneedling, PRP, fillers, subcision) within the last 3 months. 11. Patients unable to complete follow-up or not willing to avoid concurrent scar treatments during the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in acne scar severity based on the Goodman & Baron quantitative grading system from baseline to 3 and 6 months after treatment.Timepoint: After 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in scar depth, volume, pigmentation, and vascularity assessed by Antera 3D and Quantificare imaging, improvement in patient-reported outcomes using SCARS and FASQoL questionnaires, and documentation of adverse events such as erythema, edema, bruising, or post-inflammatory hyperpigmentation during follow-up at 3 and 6 months.Timepoint: After 6 months | — |
Countries
India
Contacts
Public ContactDr Kusuma MR
CUTIS Academy of Cutaneous Sciences
Outcome results
None listed